Vaxxa AB Statistics

Total Valuation

Vaxxa AB has a market cap or net worth of SEK 44.67 million. The enterprise value is 37.59 million.

Market Cap	44.67M
Enterprise Value	37.59M

Important Dates

The next estimated earnings date is Thursday, February 20, 2025.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Vaxxa AB has 37.23 million shares outstanding. The number of shares has decreased by -97.98% in one year.

Current Share Class	n/a
Shares Outstanding	37.23M
Shares Change (YoY)	-97.98%
Shares Change (QoQ)	+4.32%
Owned by Insiders (%)	63.55%
Owned by Institutions (%)	n/a
Float	13.57M

Valuation Ratios

The trailing PE ratio is 139.75.

PE Ratio	139.75
Forward PE	n/a
PS Ratio	0.43
PB Ratio	2.29
P/TBV Ratio	3.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	131.42
EV / Sales	0.41
EV / EBITDA	8.65
EV / EBIT	96.37
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.03.

Current Ratio	2.14
Quick Ratio	2.08
Debt / Equity	0.03
Debt / EBITDA	0.12
Debt / FCF	n/a
Interest Coverage	11.14

Financial Efficiency

Return on equity (ROE) is 2.03% and return on invested capital (ROIC) is 1.56%.

Return on Equity (ROE)	2.03%
Return on Assets (ROA)	1.17%
Return on Invested Capital (ROIC)	1.56%
Return on Capital Employed (ROCE)	2.16%
Revenue Per Employee	13.20M
Profits Per Employee	40,857
Employee Count	6
Asset Turnover	4.43
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.34% in the last 52 weeks. The beta is 0.42, so Vaxxa AB's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+22.34%
50-Day Moving Average	1.17
200-Day Moving Average	1.15
Relative Strength Index (RSI)	59.26
Average Volume (20 Days)	80,120

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vaxxa AB had revenue of SEK 92.40 million and earned 286,000 in profits. Earnings per share was 0.01.

Revenue	92.40M
Gross Profit	7.19M
Operating Income	390,000
Pretax Income	286,000
Net Income	286,000
EBITDA	4.34M
EBIT	390,000
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 7.63 million in cash and 540,000 in debt, giving a net cash position of 7.09 million or 0.19 per share.

Cash & Cash Equivalents	7.63M
Total Debt	540,000
Net Cash	7.09M
Net Cash Per Share	0.19
Equity (Book Value)	17.48M
Book Value Per Share	0.52
Working Capital	6.92M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 7.78%, with operating and profit margins of 0.42% and 0.31%.

Gross Margin	7.78%
Operating Margin	0.42%
Pretax Margin	0.31%
Profit Margin	0.31%
EBITDA Margin	4.70%
EBIT Margin	0.42%
FCF Margin	n/a

Dividends & Yields

Vaxxa AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	97.98%
Shareholder Yield	97.98%
Earnings Yield	0.64%
FCF Yield	n/a

Stock Splits

The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.

Last Split Date	Mar 14, 2024
Split Type	Reverse
Split Ratio	0.01

Scores

Vaxxa AB has an Altman Z-Score of 7.62.

Altman Z-Score	7.62
Piotroski F-Score	n/a